Access 2.8M+ Filings Sign Up Free
Abliva Logo

Abliva | ABLI - Profile, Filings, Stock Info & Investor Relations Data

Abliva | ABLI
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Biotechnology
Country
Sweden
Founded
2000
Abliva (ABLI)

Company Profile

Website
Investor Relations

About Abliva

Abliva develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare and often very severe diseases occur when the cell's energy provider, the mitochondria, do not function properly.

The company is focused on two projects. KL1333, a powerful NAD⁺ regulator, is in clinical development and has been granted orphan drug designation in Europe and the US. NV354, an energy replacement (succinate) therapy, will enter the clinic in 2022.

Market Presence

Worldwide

Headquarters

Medicon Village
223 81, Lund
Sweden

Company Video

Video thumbnail
Click to load video from YouTube

Abliva (ABLI)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Create Free Account Sign In

Abliva (ABLI)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

↓
David Bejker (Other)
Sell SEK 121,052.25 SEK 0.45 07.02.25
◆
Catharina Janzon Johansson (Other)
Other SEK 60,000.00 SEK 0.03 31.05.24
◆
David Laskow-Pooley (Other)
Other SEK 30,000.00 SEK 0.03 28.05.24
↑
David Laskow-Pooley (Other)
Buy SEK 11,664.58 SEK 0.21 13.07.23
↑
David Laskow-Pooley (Other)
Buy SEK 8,151.00 SEK 0.21 13.07.23
↑
David Laskow-Pooley (Other)
Buy SEK 7,807.86 SEK 0.21 13.07.23
↑
David Laskow-Pooley (Other)
Buy SEK 3,267.20 SEK 0.21 13.07.23
↑
David Laskow-Pooley (Other)
Buy SEK 2,588.47 SEK 0.21 13.07.23
↑
David Laskow-Pooley (Other)
Buy SEK 2,479.40 SEK 0.22 13.07.23
↑
David Laskow-Pooley (Other)
Buy SEK 2,474.86 SEK 0.21 13.07.23

Abliva (ABLI)
Stock & Investor Information

ISINs

SE0002575340

LEI

5493005YV22OTMUHZ183

Stock Exchange Listings

Nasdaq Stockholm

Industry Classification

Sector
Health Care
Industry
Biotechnology